Mondobiotech Aktie
WKN: A3EFB5
ISIN: CH1251125998
Land: Schweiz
Branche: Chemie, Pharma, Bio- & Medizintechnik
Sektor: Biotechnologie
2,33 EUR 0,00 EUR 0,00 %
08:25:30 Frankfurt
Komplette Navigation anzeigen

News und Analysen

Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 20-Jun-2025 / 07:00 CET/CEST Release of an ad ...weiterlesen

12.06.25
Relief Therapeutics Announces Results of Annual General Meeting
22.05.25
Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011
15.05.25
Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
06.03.25
Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion
11.02.25
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011
22.01.25
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
27.12.24
Relief Therapeutics Provides Update on Potential Transaction with Renexxion
16.12.24
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
13.12.24
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations
Seite: 1 | 2 | 3 | 4 | ►

Jetzt neu: